IGM Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
IGM Biosciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $3.46 million as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-03-06
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.46M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $4.04M; Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value as first filed $6.70M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $16.75M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $32.92M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value as first filed |
|---|---|---|
| 2024-12-31 | $3.46M 10-K · filed 2025-03-06 | |
| 2023-12-31 | $4.04M 10-Q · filed 2024-11-08 | $6.70M 10-K · filed 2024-03-07 |
| 2022-12-31 | $16.75M 10-K · filed 2023-03-30 | |
| 2021-12-31 | $32.92M 10-K · filed 2022-03-29 | |
| 2020-12-31 | $119.46M 10-K · filed 2021-03-30 | |
| 2019-12-31 | $36.21M 10-K · filed 2020-03-26 |